Drugs Information: Daratumumab

Basic Information

ID DDInter478
Drug Type biotech
Molecular Formula C6466H9996N1724O2010S42
Molecular Weight -
Description Daratumumab is a CD38-directed cytolytic antibody used alone or as an adjunct drug in the treatment of multiple myeloma.
ATC Classification L01XC24
IUPAC Name None
InChI None
InChI Key None
Canonical SMILES None
Useful Links DrugBank

Interactions with Daratumumab

Severity level ID Name Mechanism Detail